Patents by Inventor Ivo Caers

Ivo Caers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For The Treatment Of Depression
    Publication number: 20230089113
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: April 22, 2022
    Publication date: March 23, 2023
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Maria Canuso, Margaret Fedgchin, Frank Wiegand, Giacomo Salvadore
  • Methods for the treatment of depression
    Patent number: 11311500
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: April 26, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Methods for the treatment of depression
    Patent number: 11173134
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: November 16, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Methods For The Treatment Of Depression
    Publication number: 20210308076
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: June 11, 2021
    Publication date: October 7, 2021
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Methods For The Treatment Of Depression
    Publication number: 20210106545
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Methods for the treatment of depression
    Patent number: 10869844
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: December 22, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Methods For The Treatment Of Depression
    Publication number: 20200246279
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: December 26, 2019
    Publication date: August 6, 2020
    Inventors: Lodewijk Ivo Caers, Giacomo Salvadore, Jaskaran Singh
  • METHODS AND KITS FOR TREATING DEPRESSION
    Publication number: 20160338977
    Abstract: The present invention is directed to, inter alia, methods and kits for the treatment of depression (preferably, treatment resistant depression), or for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations) comprising administering esketamine according to certain dosing regimens.
    Type: Application
    Filed: May 19, 2016
    Publication date: November 24, 2016
    Applicant: Janssen Pharmaceutica NV
    Inventors: Jaskaran Singh, Ivo Caers, Ella Daly, Wayne Drevets
  • VAL66MET (SNP rs6265) GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR THE TREATMENT OF DEPRESSION
    Publication number: 20160074340
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations) comprising genotyping a patient to determine their Val66Met rs6265 polymorphism in BDNF and administering a ketamine, preferably esketamine, preferably intranasal esketamine, according to a dosing regimen matched to the patient's genotype.
    Type: Application
    Filed: September 14, 2015
    Publication date: March 17, 2016
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: LODEWIJK IVO CAERS, GIACOMO SALVADORE, JASKARAN SINGH
  • ESKETAMINE FOR THE TREATMENT OF TREATMENT-REFRACTORY OR TREATMENT-RESISTANT DEPRESSION
    Publication number: 20140093592
    Abstract: The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising administering to a patient in need thereof, a therapeutically effective amount of esketamine as mono-therapy or as combination therapy with at least on antidepressant.
    Type: Application
    Filed: December 5, 2013
    Publication date: April 3, 2014
    Applicant: Janssen Pharmaceutica NV
    Inventors: Jaskaran Singh, Lodewijk Ivo Caers
  • ESKETAMINE FOR THE TREATMENT OF TREATMENT-REFRACTORY OR TREATMENT-RESISTANT DEPRESSION
    Publication number: 20130236573
    Abstract: The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising administering to a patient in need thereof, a therapeutically effective amount of esketamine as mono-therapy or as combination therapy with at least on antidepressant.
    Type: Application
    Filed: March 12, 2013
    Publication date: September 12, 2013
    Inventors: Jaskaran Singh, Ivo Caers
  • Production of olefin dimers and oligomers
    Patent number: 6770791
    Abstract: Disclosed is an olefin containing stream from an oxygenate to olefin process, and a process for making olefin dimer and oligomer product from the olefin containing stream using a nickel based oligomerization catalyst. The dimer/oligomer product is optionally converted to hydroformylated product. The olefin containing stream that is used to make the higher olefin product has low levels of impurities including nitrogen, sulfur and/or chlorine.
    Type: Grant
    Filed: April 29, 2003
    Date of Patent: August 3, 2004
    Assignee: ExxonMobil Chemical Patents Inc.
    Inventors: Georges Mathys, John Stephen Godsmark, Marcel Janssen, Luc Roger Martens, Hubertus Joseph Beckers, Eddy Theophile Andrea Van Driessche, Raphael Frans Ivo Caers, John Richard Shutt
  • Catalysts and processes using them
    Patent number: 6680272
    Abstract: Co-precipitated CoCuMn and CoCuMg catalysts are used in Fischer-Tropsch synthesis.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: January 20, 2004
    Assignee: ExxonMobil Chemical Patents Inc.
    Inventors: Philippe Buess, Raphael Frans Ivo Caers, Alfred Frennet, Eric Ghenne, Claude Hubert, Norbert Kruse
  • Production of olefin dimers and oligomers
    Publication number: 20030225307
    Abstract: Disclosed is an olefin containing stream from an oxygenate to olefin process, and a process for making olefin dimer and oligomer product from the olefin containing stream using a nickel based oligomerization catalyst. The dimer/oligomer product is optionally converted to hydroformylated product. The olefin containing stream that is used to make the higher olefin product has low levels of impurities including nitrogen, sulfur and/or chlorine.
    Type: Application
    Filed: April 29, 2003
    Publication date: December 4, 2003
    Inventors: Georges Mathys, John Stephen Godsmark, Marcel Janssen, Luc Roger Martens, Hubertus Joseph Beckers, Eddy Theophile Andrea Van Driessche, Raphael Frans Ivo Caers, John Richard Shutt
  • Catalysts and processes using them
    Publication number: 20030036573
    Abstract: Co-precipitated CoCuMn and CoCuMg catalysts are used in Fischer-Tropsch synthesis.
    Type: Application
    Filed: December 11, 2001
    Publication date: February 20, 2003
    Inventors: Philippe Buess, Raphael Frans Ivo Caers, Alfred Frennet, Eric Ghenne, Claude Hubert, Norbert Kruse
  • Production of olefin dimers and oligomers
    Publication number: 20020103406
    Abstract: Disclosed is an olefin containing stream from an oxygenate to olefin process, and a process for making olefin dimer and oligomer product from the olefin containing stream using a nickel based oligomerization catalyst. The dimer/oligomer product is optionally converted to hydroformylated product. The olefin containing stream that is used to make the higher olefin product has low levels of impurities including nitrogen, sulfur and/or chlorine.
    Type: Application
    Filed: October 26, 2001
    Publication date: August 1, 2002
    Inventors: Georges Mathys, John Stephen Godsmark, Marcel Janssen, Luc Roger Martens, Hubertus Joseph Beckers, Eddy Theophile Andrea Van Driessche, Raphael Frans Ivo Caers, John Richard Shutt
  • Catalysts and processes using them
    Patent number: 6362239
    Abstract: Co-precipitated CoCuMn and CoCuMg catalysts are used in Fischer-Tropsch synthesis.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: March 26, 2002
    Assignee: ExxonMobil Chemical Patents Inc.
    Inventors: Philippe Buess, Raphael Frans Ivo Caers, Alfred Frennet, Eric Ghenne, Claude Hubert, Norbert Kruse
  • Esters, ethers, and compositions comprising them
    Patent number: 6274756
    Abstract: Esters and ethers of 2,4,6-trimethylnonanol, compositions comprising them, their uses, and processes for their manufacture.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: August 14, 2001
    Assignee: Exxon Chemicals Patents, Inc.
    Inventors: Raphael Frans Ivo Caers, Richard Henry Schlosberg